Our team has come to know that the US government will purchase around 1.13 million doses of a pair of Ebola vaccines and treatments which will aid in keeping a hand in the event of another outbreak. The government is not going to compromise on the health of its citizens. This news was stated to the public by the Biomedical Advanced Research and Development Authority.
BARDA which is a part of the Department of Health and Human Services is planning to spend around $170 million to stockpile two vaccines and two treatments. While the authority can keep purchasing the drugs, none have been approved for the use by the Food and Drugs Administration. According to a report submitted by Reuters, BARDA will come forward to assist each manufacturer “validate its manufacturing processes and make final preparations needed to apply for FDA approval.” It will still have the authority to keep a stockpile of the drugs on hand, regardless of the arrival of the approval.
We know that the authority is purchasing the drugs through the Project BioShield Act. It is a law designed in the year 2004 to stockpile treatments for chemical, biological, nuclear incidents for the country’s civilian population. This comes after the West African Ebola Outbreak which infected 28,616 and raised the death toll to 11,310 people between the year 2013 and 2016. In the United States of America, four cases were reported, of which one resulted in death.
Since the outbreak, various efforts have been made to find treatments for the often-fatal disease. A 2016 trial of a drug that was manufactured by Merck and Co. in Guinea and Sierra Leone gave some highly effective results. There are other organizers who are aiding in this motive to free the world from this alarming issue. Earlier this week, the National Institutes of Health granted the Thomas Jefferson University an amount of $2.6 million. The grant was given to develop a new vaccine to fight the Ebola, Marburg, and Lassa fever viruses.
The Ebola virus first surfaced in the region of Central Africa in the 1970s and is considered to be transmitted to humans through animal contact. The people who become a victim to this experience fever, headaches, and muscle pain which is followed by vomiting, diarrhea and in rare cases internal/external bleeding. Since the time of its discovery, it has come up in small outbreaks. In 2013, the killing disease appeared in West Africa and from there it quickly spread throughout 10 countries. It took people months to bring it under control. Only this summer, four people lost their lives due to a small outbreak in the Democratic Republic of the Congo. Fortunately, the outbreak was controlled within 42 days without the use of the new vaccines or treatment.